Literature DB >> 98600

Phenotypic and epidemiologic correlates of auxotype in Neisseria gonorrhoeae.

J S Knapp, C Thornsberry, G A Schoolnik, P J Wiesner, K K Homes.   

Abstract

Previous studies from Seattle, Wash., suggested that strains of Neisseria gonorrhoeae which require arginine, hypoxanthine, and uracil (Arg-Hyx-Ura- auxotype) are unifomly highly susceptible to penicillin G, are relatively resistant to complement-dependent killing by heated, pooled human serum, and are associated with disseminated gonococcal infection. For further study of the epidemiology of these strains and for analysis of the susceptibility to penicillin, serum sensitivity, and the nutritional requirements of gonococcal isolates from other cities, a survey was made of urethral and cervical strains isolated in 1972--1974 from 50 randomly selected pateit-s with uncomplicated gonorrhea from each of nine cities. Arg-Hyx-Ura-strains represented greater than 50% of isolates from Seattle and Des Moines, Iowa, 22% of isolates from Denver, Colo., and Dayton, Ohio, and less than or equal to 12% of the isolates from Boston, Mass., Newark, N.J., Norfork, Va., Miami, Fla., and Oakland, Calif. Arg-Hyx-Ura- strains were recovered from 42% of white and 9% of black patients (P less than 0.001), and clincis with the highest incidences of these strains had the highest proportion of white patients among those with gonorrhea. Arg-Hyx-Ura- strains were all susceptible to less than or equal to 0.125 microgram of penicillin G/ml and were more resistant than strains with other auxotypes to killing by heat-inactivated human serum plus complement (P less than 0.001).

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 98600     DOI: 10.1093/infdis/138.2.160

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  New complementation constructs for inducible and constitutive gene expression in Neisseria gonorrhoeae and Neisseria meningitidis.

Authors:  Meghan E Ramsey; Kathleen T Hackett; Chaitra Kotha; Joseph P Dillard
Journal:  Appl Environ Microbiol       Date:  2012-02-10       Impact factor: 4.792

2.  Associations between serotype and susceptibility to antibiotics of Neisseria gonorrhoeae.

Authors:  N Woodford; K M Bindayna; C S Easmon; C A Ison
Journal:  Genitourin Med       Date:  1989-04

Review 3.  Molecular epidemiology of gonorrhea.

Authors:  S K Sarafian; J S Knapp
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

4.  Epidemiological analysis of Neisseria gonorrhoeae in the Federal Republic of Germany by auxotyping and serological classification using monoclonal antibodies.

Authors:  P K Kohl; J S Knapp; H Hofmann; K Gruender; D Petzoldt; M R Tams; K K Holmes
Journal:  Genitourin Med       Date:  1986-06

5.  Autoplaquing in Neisseria gonorrhoeae.

Authors:  L A Campbell; H B Short; F E Young; V L Clark
Journal:  J Bacteriol       Date:  1985-10       Impact factor: 3.490

6.  Epidemiological studies on Neisseria gonorrhoeae isolated in the United Kingdom.

Authors:  C G Copley; K Gough; S I Egglestone
Journal:  Eur J Epidemiol       Date:  1985-09       Impact factor: 8.082

7.  Neisseria gonorrhoeae: stability of typing markers after natural transmission.

Authors:  C G Copley; C P Chiswell; S I Egglestone
Journal:  Br J Vener Dis       Date:  1983-08

8.  Distribution of auxotypes and correlation to antibiotic susceptibility of 169 recent clinical Neisseria gonorrhoeae isolates from Munich.

Authors:  G Ruckdeschel; U Neubert; H C Korting
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

9.  Isolation of Neisseria gonorrhoeae on selective and nonselective media in a sexually transmitted disease clinic.

Authors:  P Bonin; T T Tanino; H H Handsfield
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

10.  Naturally occurring auxotrophs of Campylobacter jejuni and Campylobacter coli.

Authors:  F C Tenover; C M Patton
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.